North Growth Management Ltd. / BMY
North Growth Management Ltd.’s Bristol-Myers Squibb Co Position
Does North Growth Management Ltd. own Bristol-Myers Squibb Co (BMY)? Not currently — the last reported position was 195.0K shares worth $11M in Q3 2023; the fund’s latest 13F (Q1 2026) no longer reports it.
Position Value
$11M
Q3 2023
Shares
195.0K
% of Portfolio
+2.50%
Quarters Held
18
position exited
Position History BMY
Reported value by quarter
| Quarter | Shares | Value | % of Portfolio |
|---|---|---|---|
| Q3 2023 | 195.0K | $11M | +2.50% |
| Q2 2023 | 220.0K | $14M | +2.89% |
| Q1 2023 | 220.0K | $15M | +3.25% |
| Q4 2022 | 223.0K | $16M | +3.65% |
| Q3 2022 | 255.0K | $18M | +4.52% |
| Q2 2022 | 255.0K | $20M | +4.55% |
| Q1 2022 | 255.0K | $19M | +3.43% |
| Q4 2021 | 253.0K | $16M | +2.62% |
| Q3 2021 | 253.0K | $15M | +2.64% |
| Q2 2021 | 253.0K | $17M | +2.74% |
| Q1 2021 | 233.0K | $15M | +2.60% |
| Q4 2020 | 210.0K | $13M | +2.67% |
| Q3 2020 | 226.0K | $14M | +3.00% |
| Q2 2020 | 206.0K | $12M | +2.90% |
| Q1 2020 | 186.0K | $10M | +2.92% |
| Q4 2019 | 148.0K | $10M | +2.14% |
| Q3 2019 | 148.0K | $8M | +1.82% |
| Q2 2019 | 102.0K | $5M | +1.15% |
Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See North Growth Management Ltd.’s full portfolio or all institutional holders of BMY.